Robb Gary Charles sold CORT
August 17, 2026 · Form 4 insider transaction
Robb Gary Charles sold 10,000 shares of Corcept Therapeutics Incorporated at $116.26 per share, a transaction worth $1.16M. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
10,000
Price
$116.26
Total value
$1.16M
InsiderRobb Gary Charles
RoleOfficer
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateAugust 17, 2026
Filing dateAugust 18, 2026
Shares owned after39,716
OwnershipIndirect
10b5-1 planNo
AmendedNo
Footnotes
Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $116.00 to $116.54 per share. Information on the exact number of shares sold at each sale price can be obtained from the issuer upon request.; These shares are held by Gary Charles Robb TTE Robb Revocable Trust of which the Reporting Person is trustee.